96-32607. Manufacturer of Controlled Substances; Notice of Application  

  • [Federal Register Volume 61, Number 248 (Tuesday, December 24, 1996)]
    [Notices]
    [Pages 67853-67854]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 96-32607]
    
    
    -----------------------------------------------------------------------
    
    
    DEPARTMENT OF JUSTICE
    
    Manufacturer of Controlled Substances; Notice of Application
    
        Pursuant to Sec. 1301.43(a) of Title 21 of the Code of Federal 
    Regulations (CFR), this is notice that on October 2, 1996, Radian 
    International LLC, 8501 North Mopac Blvd., P.O. Box 201088, Austin, 
    Texas 78720, made application by letter dated October 2, 1996, to the 
    Drug Enforcement Administration (DEA) for registration as a bulk 
    manufacturer of the basic classes of controlled substances listed 
    below:
    
    ------------------------------------------------------------------------
                                Drug                               Schedule 
    ------------------------------------------------------------------------
    Alpha-Ethyltryptamine (7249)................................          I 
    3,4,5-Trimethoxyamphetamine (7390)..........................          I 
    4-Bromo-2,5-dimethoxyamphetamine (7391).....................          I 
    4-Bromo-2,5-dimethoxyphenethylamine (7392)..................          I 
    4-Methyl-2,5-dimethoxyamphetamine (7395)....................          I 
    2,5-Dimethoxyamphetamine (7396).............................          I 
    2,5-Dimethoxy-4-ethylamphetamine (7399).....................          I 
    5-Methoxy-3,4-methylenedioxyamphetamine (7401)..............          I 
    N-Hydroxy-3,4-methylenedioxyamphetamine (7402)..............          I 
    Bufotenine (7433)...........................................          I 
    Codeine-N-oxide (9053)......................................          I 
    Heroin (9200)...............................................          I 
    Morphine-N-oxide (9307).....................................          I 
    Pholcodine (9314)...........................................          I 
    Alphamethadol (9605)........................................          I 
    Betcetylmethadol (9607).....................................          I 
    Betamethadol (9609).........................................          I 
    Norlevorphanol (9634).......................................          I 
    Para-Fluorofentanyl (9812)..................................          I 
    Alpha-methylfentanyl (9814).................................          I 
    Acetyl-alpha-methylfentanyl (9815)..........................          I 
    Beta-hydroxyfentanyl (9830).................................          I 
    Beta-hydroxy-3-methylfentanyl (9831)........................          I 
    Alpha-Methylthiofentanyl (9832).............................          I 
    3-Methylthiofentanyl (9833).................................          I 
    Thiofentanyl (9835).........................................          I 
    Phenmetrazine (1631)........................................         II 
    Glutethimide (2550).........................................         II 
    Cocaine (9041)..............................................         II 
    Codeine (9050)..............................................         II 
    Levomethorphan (9210).......................................         II 
    
    [[Page 67854]]
    
                                                                            
    Levorphanol (9220)..........................................         II 
    ------------------------------------------------------------------------
    
        The firm plans to manufacture small quantities of the listed 
    controlled substances to make deuterated and non-deuterated drug 
    reference standards which will be distributed to analytical and 
    forensic laboratories for drug testing programs.
        Any other such applicant and any person who is presently registered 
    with DEA to manufacture such substances may file comments or objections 
    to the issuance of the above application.
        Any such comments or objections may be addressed, in quintuplicate, 
    to the Deputy Assistant Administrator, Office of Diversion Control, 
    Drug Enforcement Administration, United States Department of Justice, 
    Washington, D.C. Federal Register Representative (CCR), and must be 
    filed no later than February 24, 1997.
    
        Dated: November 19, 1996.
    Gene R. Haislip,
    Deputy Assistant Administrator, Office of Diversion Control, Drug 
    Enforcement Administration.
    [FR Doc. 96-32607 Filed 12-23-96; 8:45 am]
    BILLING CODE 4410-09-M
    
    
    

Document Information

Published:
12/24/1996
Department:
Justice Department
Entry Type:
Notice
Document Number:
96-32607
Pages:
67853-67854 (2 pages)
PDF File:
96-32607.pdf